Skip to main content
CIN- L67120MH1995PLC084899
  

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID



Biocon Ltd.

NSE : BIOCONEQ BSE : 532523 ISIN CODE : INE376G01013Industry : Pharmaceuticals

News

  • Biocon - Updates 25 Sep 2026 | 08:36 | Dion Global

    Biocon Limited has informed the Exchange regarding Company Statement .more...

  • Biocon - Company Secretary 25 Sep 2026 | 08:33 | Dion Global

    Company Secretarymore...

  • Biocon arm gets positive EMA panel recommendation for breast cancer biosimilar pebrilzo 21 Sep 2026 | 12:14 | Dion Global

    Biocon s wholly owned subsidiary Biocon Biologics has received a positive recommendation from the European Medicines Agency s (EMA) Committee for Med...more...

  • Biocon - Announcement under Regulation 30 (LODR)-Press Release / Media Release 21 Sep 2026 | 08:29 | Dion Global

    Press Releasemore...

  • Biocon - Press Release 21 Sep 2026 | 08:27 | Dion Global

    Biocon Limited has informed the Exchange regarding a press release dated September 21 2026 titled Biocon s Pertuzumab Becomes First Biosimilar to Sec...more...

  • Biocon - Communication Regarding Remittance Of Final Dividend For The FY 2025-26 09 Sep 2026 | 14:03 | Dion Global

    Communication regarding remittance of final dividend for the FY 2025-26more...

  • Biocon - General Updates 09 Sep 2026 | 13:59 | Dion Global

    Biocon Limited has informed the Exchange about Communication regarding remittance of final dividend for the FY 2025-26more...

  • Biocon - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 08 Sep 2026 | 16:03 | Dion Global

    Intimation of Schedule of Meetings with Analyst(s)/Institutional Investor(s)more...

  • Biocon - Analysts/Institutional Investor Meet/Con. Call Updates 08 Sep 2026 | 15:57 | Dion Global

    Biocon Limited has informed the Exchange about Schedule of meetmore...

  • Biocon secures 10-year Pertuzumab supply contract in Brazil 08 Sep 2026 | 10:50 | Dion Global

    Biocon Ltd has signed a partnership agreement with Bahiafarma and Bionovis for the production and commercialisation of Pertuzumab in Brazil ...more...

  • Biocon - Announcement under Regulation 30 (LODR)-Press Release / Media Release 08 Sep 2026 | 08:32 | Dion Global

    Press Releasemore...

  • Biocon - Press Release 08 Sep 2026 | 08:31 | Dion Global

    Biocon Limited has informed the Exchange regarding a press release dated September 08 2026 titled Biocon Secures 10-Year Supply Contract for...more...

  • Biocon - Analysts/Institutional Investor Meet/Con. Call Updates 31 Aug 2026 | 18:04 | Dion Global

    Biocon Limited has informed the Exchange about Schedule of meetmore...

  • Biocon - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 31 Aug 2026 | 18:03 | Dion Global

    Intimation of Schedule of Meetings with Analyst(s)/Institutional Investor(s)more...

  • Biocon - General Updates 28 Aug 2026 | 21:00 | Dion Global

    Biocon Limited has informed the Exchange about Communication regarding remittance of final dividend for the FY 2025-26more...

  • Biocon - Communication Regarding Remittance Of Final Dividend For The FY 2025-26 28 Aug 2026 | 20:58 | Dion Global

    Communication regarding remittance of final dividend for the FY 2025-26more...

  • Biocon Biologics gets Japanese approval for pegfilgrastim biosimilar 25 Aug 2026 | 10:48 | Dion Global

    Biocon Ltd on Tuesday announced that its subsidiary Biocon Biologics has secured marketing authorisation for its pegfilgrastim biosimilar from Japan ...more...

  • Biocon - Company Statement 25 Aug 2026 | 08:30 | Dion Global

    Company Statementmore...

  • Biocon - Updates 25 Aug 2026 | 08:29 | Dion Global

    Biocon Limited has informed the Exchange regarding Company Statement .more...

  • Biocon posts Q1 net profit of Rs 52.20 cr 19 Aug 2026 | 20:20 | Dion Global

    The company reported standalone net profit during the quarter stood at Rs 52.20 crore compared to net loss of Rs 8.30 crore in the previous ...more...


Global Indices table showing index names, current values, and percentage changes
Index Name Current Value Direction Change (%)
DOW Jones45473.55Up0.16%
Nasdaq21794.16Up0.43%
S&P 5006496.04Up0.22%
Nikkei 22543643.81Up1.45%
Hang Seng25633.91Up0.85%
Shanghai Composite3826.84Up0.38%

Indian Indices table showing index names, current values, and percentage changes
Index Name Current Value Direction Change (%)
Sensex72771.72Down-1.52%
NSE Index22780.25Down-1.55%
B500DIVL503385.82Down-1.32%
BSE 1000 10462.24Down-1.60%
BSE 100LCTMC8623.33Down-1.58%
BSE Auto 58685.18Down-1.61%

Commodity


Commodity prices table showing commodity names, current prices, and percentage changes
Commodity Name Current Price Direction Change (%)
Gold146884Down-2.97%
Silver222325Down-4.08%
Copper1422.5Up248.82%
Crude Oil8861Up38.17%
Lead196Up45.83%
Mentha Oil1356.3Up27.07%
Nickel1593Up107.72%

Currency


Currency exchange rates table showing currency pairs, exchange rates, and percentage changes
Currency Pair Exchange Rate Direction
USD/INR95.7900 (-0.09%)Down
GBP/INR128.0900 (-0.24%)Down
EUR/INR109.9900 (-0.05%)Down
JPY/INR0.6100 (-1.00%)Down
CAD/INR68.9200 (0.56%)Up
HKD/INR12.1300 (-0.74%)Down


Announcement Calendar

Previous monthSeptember 2026Next month
MonTueWedThuFriSatSun
311 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 1234
567891011

Upcoming

BOARD MEETINGS
Company Name : LCC Projects
Date : 05-10-2026